182 related articles for article (PubMed ID: 1624634)
1. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers.
Falanga V; Eaglstein WH; Bucalo B; Katz MH; Harris B; Carson P
J Dermatol Surg Oncol; 1992 Jul; 18(7):604-6. PubMed ID: 1624634
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind clinical trial examining the effect of oral human recombinant epidermal growth factor on the healing of duodenal ulcers.
Palomino A; Hernández-Bernal F; Haedo W; Franco S; Más JA; Fernández JA; Soto G; Alonso A; González T; López-Saura P
Scand J Gastroenterol; 2000 Oct; 35(10):1016-22. PubMed ID: 11099053
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
[TBL] [Abstract][Full Text] [Related]
4. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.
Fernández-Montequín JI; Valenzuela-Silva CM; Díaz OG; Savigne W; Sancho-Soutelo N; Rivero-Fernández F; Sánchez-Penton P; Morejón-Vega L; Artaza-Sanz H; García-Herrera A; González-Benavides C; Hernández-Cañete CM; Vázquez-Proenza A; Berlanga-Acosta J; López-Saura PA;
Int Wound J; 2009 Dec; 6(6):432-43. PubMed ID: 20051095
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers.
Jaschke E; Zabernigg A; Gattringer C
Int J Dermatol; 1999 May; 38(5):380-6. PubMed ID: 10369552
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers.
Robson MC; Phillips TJ; Falanga V; Odenheimer DJ; Parish LC; Jensen JL; Steed DL
Wound Repair Regen; 2001; 9(5):347-52. PubMed ID: 11896977
[TBL] [Abstract][Full Text] [Related]
7. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
[TBL] [Abstract][Full Text] [Related]
8. [Questionable effectiveness of autologous platelet growth factors (PDWHF) in treatment of venous ulcers of the leg].
Reutter H; Bort S; Jung MF; Klyscz T; Schippert W; Zuder D; Jünger M
Hautarzt; 1999 Dec; 50(12):859-65. PubMed ID: 10663020
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial.
Gomez-Villa R; Aguilar-Rebolledo F; Lozano-Platonoff A; Teran-Soto JM; Fabian-Victoriano MR; Kresch-Tronik NS; Garrido-Espíndola X; Garcia-Solis A; Bondani-Guasti A; Bierzwinsky-Sneider G; Contreras-Ruiz J
Wound Repair Regen; 2014; 22(4):497-503. PubMed ID: 25041620
[TBL] [Abstract][Full Text] [Related]
10. Double-blind placebo-controlled study with topical 2% ketanserin ointment in the treatment of venous ulcers.
Roelens P
Dermatologica; 1989; 178(2):98-102. PubMed ID: 2647535
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of chronic venous ulcers with sucralfate: a placebo controlled randomized study.
Tumino G; Masuelli L; Bei R; Simonelli L; Santoro A; Francipane S
Int J Mol Med; 2008 Jul; 22(1):17-23. PubMed ID: 18575771
[TBL] [Abstract][Full Text] [Related]
12. Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing.
De Sanctis MT; Belcaro G; Cesarone MR; Ippolito E; Nicolaides AN; Incandela L; Geroulakos G
Angiology; 2002; 53 Suppl 1():S49-51. PubMed ID: 11865837
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor in the topical treatment of traumatic corneal ulcers.
Scardovi C; De Felice GP; Gazzaniga A
Ophthalmologica; 1993; 206(3):119-24. PubMed ID: 8272333
[TBL] [Abstract][Full Text] [Related]
14. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers.
Vowden P; Romanelli M; Peter R; Boström A; Josefsson A; Stege H
Wound Repair Regen; 2006; 14(3):240-6. PubMed ID: 16808801
[TBL] [Abstract][Full Text] [Related]
15. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous leg ulcers with topical iloprost: a placebo controlled study.
Werner-Schlenzka H; Kuhlmann RK
Vasa; 1994; 23(2):145-50. PubMed ID: 7518629
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.
Steed DL
J Vasc Surg; 1995 Jan; 21(1):71-8; discussion 79-81. PubMed ID: 7823364
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor and epidermal growth factor reverse impaired ulcer healing of the rabbit oral mucosa.
Fujisawa K; Miyamoto Y; Nagayama M
J Oral Pathol Med; 2003 Jul; 32(6):358-66. PubMed ID: 12787043
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial.
Falanga V; Fujitani RM; Diaz C; Hunter G; Jorizzo J; Lawrence PF; Lee BY; Menzoian JO; Tretbar LL; Holloway GA; Hoballah J; Seabrook GR; McMillan DE; Wolf W
Wound Repair Regen; 1999; 7(4):208-13. PubMed ID: 10781212
[TBL] [Abstract][Full Text] [Related]
20. Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers.
Peschen M; Thimm C; Weyl A; Weiss JM; Kurz H; Augustin M; Simon JC; Schöpf E; Vanscheidt W
Vasa; 1998 May; 27(2):89-93. PubMed ID: 9612112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
